Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning

被引:7
|
作者
Moravek, Zdenek [1 ]
Rickhey, Mark [1 ]
Hartmann, Matthias [2 ]
Bogner, Ludwig [1 ]
机构
[1] Univ Hosp Regensburg, Dept Radiat Oncol, Regensburg, Germany
[2] Paul Scherrer Inst, Ctr Proton Therapy, Villigen, Switzerland
关键词
DOSE CALCULATION; PHOTON BEAMS; OPTIMIZATION; RADIOTHERAPY; SENSITIVITY; ALGORITHM; IMRT;
D O I
10.1088/0031-9155/54/15/011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Treatment plans for intensity-modulated proton therapy may be sensitive to some sources of uncertainty. One source is correlated with approximations of the algorithms applied in the treatment planning system and another one depends on how robust the optimization is with regard to intra-fractional tissue movements. The irradiated dose distribution may substantially deteriorate from the planning when systematic errors occur in the dose algorithm. This can influence proton ranges and lead to improper modeling of the Braggpeak degradation in heterogeneous structures or particle scatter or the nuclear interaction part. Additionally, systematic errors influence the optimization process, which leads to the convergence error. Uncertainties with regard to organ movements are related to the robustness of a chosen beam setup to tissue movements on irradiation. We present the inverse Monte Carlo treatment planning system IKO for protons (IKO-P), which tries to minimize the errors described above to a large extent. Additionally, robust planning is introduced by beam angle optimization according to an objective function penalizing paths representing strongly longitudinal and transversal tissue heterogeneities. The same score function is applied to optimize spot planning by the selection of a robust choice of spots. As spots can be positioned on different energy grids or on geometric grids with different space filling factors, a variety of grids were used to investigate the influence on the spot-weight distribution as a result of optimization. A tighter distribution of spot weights was assumed to result in a more robust plan with respect to movements. IKO-P is described in detail and demonstrated on a test case and a lung cancer case as well. Different options of spot planning and grid types are evaluated, yielding a superior plan quality with dose delivery to the spots from all beam directions over optimized beam directions. This option shows a tighter spot-weight distribution and should therefore be less sensitive to movements compared to optimized directions. But accepting a slight loss in plan quality, the latter choice could potentially improve robustness even further by accepting only spots from the most proper direction. The choice of a geometric grid instead of an energy grid for spot positioning has only a minor influence on the plan quality, at least for the investigated lung case.
引用
收藏
页码:4803 / 4819
页数:17
相关论文
共 50 条
  • [31] Intensity modulated proton therapy treatment planning using single-field optimization: The impact of monitor unit constraints on plan quality
    Zhu, X. R.
    Sahoo, N.
    Zhang, X.
    Robertson, D.
    Li, H.
    Choi, S.
    Lee, A. K.
    Gillin, M. T.
    MEDICAL PHYSICS, 2010, 37 (03) : 1210 - 1219
  • [32] Intensity Modulated Proton Therapy Treatment Planning for Postmastectomy Patients with Metallic Port Tissue Expanders
    Zhu, Mingyao
    Langen, Katja
    Nichols, Elizabeth M.
    Lin, Yuting
    Flampouri, Stella
    Godette, Karen D.
    Dutta, Sunil W.
    McDonald, Mark W.
    Patel, Sagar A.
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (01)
  • [33] Evaluation of uncertainty-based stopping criteria for Monte Carlo calculations of intensity-modulated radiotherapy and arc therapy patient dose distributions
    Vanderstraeten, Barbara
    Olteanu, Ana Maria Luiza
    Reynaert, Nick
    Leal, Antonio
    De Neve, Wilfried
    Thierens, Hubert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02): : 628 - 637
  • [34] Clinical implementation of a GPU-based simplified Monte Carlo method for a treatment planning system of proton beam therapy
    Kohno, R.
    Hotta, K.
    Nishioka, S.
    Matsubara, K.
    Tansho, R.
    Suzuki, T.
    PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (22) : N287 - N294
  • [35] Analytical incorporation of fractionation effects in probabilistic treatment planning for intensity-modulated proton therapy
    Wahl, Niklas
    Hennig, Philipp
    Wieser, Hans-Peter
    Bangert, Mark
    MEDICAL PHYSICS, 2018, 45 (04) : 1317 - 1328
  • [36] Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy
    Nicolini, Giorgia
    Clivio, Alessandro
    Fogliata, Antonella
    Vanetti, Eugenio
    Cozzi, Luca
    RADIATION ONCOLOGY, 2009, 4
  • [37] Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer
    Stefanowicz, Sarah
    Stuetzer, Kristin
    Zschaeck, Sebastian
    Jakobi, Annika
    Troost, Esther G. C.
    RADIATION ONCOLOGY, 2018, 13 : 228
  • [38] Dose differences in intensity-modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT
    Liu, Han
    Zhuang, Tingliang
    Stephans, Kevin
    Videtic, Gregory
    Raithel, Stephen
    Djemil, Toufik
    Xia, Ping
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2015, 16 (06): : 91 - 99
  • [39] Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization
    Michiels, Steven
    Barragan, Ana Maria
    Souris, Kevin
    Poels, Kenneth
    Crijns, Wouter
    Lee, John A.
    Sterpin, Edmond
    Nuyts, Sandra
    Haustermans, Karin
    Depuydt, Tom
    RADIOTHERAPY AND ONCOLOGY, 2018, 128 (01) : 161 - 166
  • [40] Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas
    Münter, MW
    Debus, J
    Hof, H
    Nill, S
    Häring, P
    Bortfeld, T
    Wannenmacher, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (09) : 517 - 523